Cargando…

Subsequent AS01-adjuvanted vaccinations induce similar transcriptional responses in populations with different disease statuses

Transcriptional responses to adjuvanted vaccines can vary substantially among populations. Interindividual diversity in levels of pathogen exposure, and thus of cell-mediated immunological memory at baseline, may be an important determinant of population differences in vaccine responses. Adjuvant Sy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Coccia, Margherita, Burny, Wivine, Demoitié, Marie-Ange, Gillard, Paul, van den Berg, Robert A., van der Most, Robbert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9648731/ https://www.ncbi.nlm.nih.gov/pubmed/36355775 http://dx.doi.org/10.1371/journal.pone.0276505

Ejemplares similares

Adjuvant-Associated Peripheral Blood mRNA Profiles and Kinetics Induced by the Adjuvanted Recombinant Protein Candidate Tuberculosis Vaccine M72/AS01 in Bacillus Calmette–Guérin-Vaccinated Adults
por: van den Berg, Robert A., et al.
Publicado: (2018)

Systems serology-based comparison of antibody effector functions induced by adjuvanted vaccines to guide vaccine design
por: Loos, Carolin, et al.
Publicado: (2023)

Safety and immunogenicity of candidate vaccine M72/AS01(E) in adolescents in a TB endemic setting
por: Penn-Nicholson, Adam, et al.
Publicado: (2015)

Different Adjuvants Induce Common Innate Pathways That Are Associated with Enhanced Adaptive Responses against a Model Antigen in Humans
por: Burny, Wivine, et al.
Publicado: (2017)

“World in motion” – emulsion adjuvants rising to meet the pandemic challenges
por: O’Hagan, Derek T., et al.
Publicado: (2021)

Author Correction: “World in motion” – emulsion adjuvants rising to meet the pandemic challenges
por: O’Hagan, Derek T., et al.
Publicado: (2023)

Cellular and molecular synergy in AS01-adjuvanted vaccines results in an early IFNγ response promoting vaccine immunogenicity
por: Coccia, Margherita, et al.
Publicado: (2017)

Author Correction: Cellular and molecular synergy in AS01-adjuvanted vaccines results in an early IFNγ response promoting vaccine immunogenicity
por: Coccia, Margherita, et al.
Publicado: (2018)

Antibody avidity, persistence, and response to antigen recall: comparison of vaccine adjuvants
por: Budroni, Sonia, et al.
Publicado: (2021)

Application of Modeling Approaches to Explore Vaccine Adjuvant Mode-of-Action
por: Buckley, Paul R., et al.
Publicado: (2019)

A Randomized Trial Assessing the Safety and Immunogenicity of AS01 and AS02 Adjuvanted RTS,S Malaria Vaccine Candidates in Children in Gabon
por: Lell, Bertrand, et al.
Publicado: (2009)

Predicting RTS,S Vaccine-Mediated Protection from Transcriptomes in a Malaria-Challenge Clinical Trial
por: van den Berg, Robert A., et al.
Publicado: (2017)

Association Between Immunogenicity and Reactogenicity: A Post Hoc Analysis of 2 Phase 3 Studies With the Adjuvanted Recombinant Zoster Vaccine
por: Callegaro, Andrea, et al.
Publicado: (2021)

Long-term safety and immunogenicity of the M72/AS01(E) candidate tuberculosis vaccine in HIV-positive and -negative Indian adults: Results from a phase II randomized controlled trial
por: Kumarasamy, Nagalingeswaran, et al.
Publicado: (2018)

A Randomized, Controlled Safety, and Immunogenicity Trial of the M72/AS01 Candidate Tuberculosis Vaccine in HIV-Positive Indian Adults
por: Kumarasamy, Nagalingeswaran, et al.
Publicado: (2016)

26. Is There a Correlation Between Reactogenicity and Immune Responses of the Adjuvanted Recombinant Zoster Vaccine (RZV)? A Post-hoc Analysis
por: Callegaro, Andrea, et al.
Publicado: (2021)

UNDERSTANDING AND ADDRESSING IMMUNOSENESCENCE
por: Van Der Most, Robbert
Publicado: (2019)

An Adjuvanted Polyprotein HIV-1 Vaccine Induces Polyfunctional Cross-Reactive CD4(+) T Cell Responses in Seronegative Volunteers
por: Van Braeckel, Eva, et al.
Publicado: (2011)

Phase 2b placebo-controlled trial of M72/AS01(E) candidate vaccine to prevent active tuberculosis in adults
por: Van Der Meeren, Olivier, et al.
Publicado: (2018)

P01-12 The Netherlands united by sport: implementtion and monitoring of the national sports agreement in 2019
por: Wendel-Vos, Wanda, et al.
Publicado: (2022)

Similarities and differences of chemical compositions and physical and functional properties of adjuvant system 01 and army liposome formulation with QS21
por: Alving, Carl R., et al.
Publicado: (2023)

120. A Randomized Double-blind Trial Assessing the Efficacy of M72/AS01(E) Vaccine Against Pulmonary Tuberculosis Disease in Adults With Latent Mycobacterium tuberculosis Infection
por: Meeren, Olivier Van Der, et al.
Publicado: (2018)

A Randomized, Controlled Dose-Finding Phase II Study of the M72/AS01 Candidate Tuberculosis Vaccine in Healthy PPD-Positive Adults
por: Montoya, Jaime, et al.
Publicado: (2013)

Narcolepsy and H1N1 influenza immunology a decade later: What have we learned?
por: Buonocore, Sofia M., et al.
Publicado: (2022)

Long-Term Persistence of Cell-Mediated and Humoral Responses to A(H1N1)pdm09 Influenza Virus Vaccines and the Role of the AS03 Adjuvant System in Adults during Two Randomized Controlled Trials
por: van der Most, Robbert G., et al.
Publicado: (2017)

Characterization of T-cell immune responses in clinical trials of the candidate RTS,S malaria vaccine
por: Moris, Philippe, et al.
Publicado: (2017)

OA01.02. Management of infertility subsequent to endometriosis –A study
por: Sindhu, A
Publicado: (2013)

OR01-05 Long-Term Efficacy of T3 Analogue Triac in MCT8 Deficiency
por: van Geest, Ferdy S, et al.
Publicado: (2020)

Purification and Characterization of Intracellular Cellulase from Aspergillus oryzae ITCC-4857.01
por: Begum, Most. Ferdousi, et al.
Publicado: (2009)

Central Role of CD169(+) Lymph Node Resident Macrophages in the Adjuvanticity of the QS-21 Component of AS01
por: Detienne, Sophie, et al.
Publicado: (2016)

Evaluation of RTS,S/AS02A and RTS,S/AS01B in Adults in a High Malaria Transmission Area
por: Polhemus, Mark E., et al.
Publicado: (2009)

Evaluation of potential immunogenicity differences between Pandemrix™ and Arepanrix™
por: Canelle, Quentin, et al.
Publicado: (2016)

Vaccination as a preventative measure contributing to immune fitness
por: Laupèze, Béatrice, et al.
Publicado: (2021)

Investigating the effect of AS03 adjuvant on the plasma cell repertoire following pH1N1 influenza vaccination
por: Galson, J. D., et al.
Publicado: (2016)

Retroviral Vector Biosafety: Lessons from Sheep
por: Van den Broeke, Anne, et al.
Publicado: (2003)

Adjuvants influence the maturation of VRC01-like antibodies during immunization
por: Knudsen, Maria L., et al.
Publicado: (2022)

CMS CONDUCTOR EBW PRODUCTION LINE AT TECHMETA - STATUS OF THE 17.01.01
por: Ramon Folch
Publicado: (2001)

Changes in body composition during and after adjuvant or neo-adjuvant chemotherapy in women with breast cancer stage I–IIIB compared with changes over a similar timeframe in women without cancer
por: van den Berg, M. M. G. A., et al.
Publicado: (2019)

Characterization of novel Bovine Leukemia Virus (BLV) antisense transcripts by deep sequencing reveals constitutive expression in tumors and transcriptional interaction with viral microRNAs
por: Durkin, Keith, et al.
Publicado: (2016)

Responses to A(H1N1)pdm09 Influenza Vaccines in Participants Previously Vaccinated With Seasonal Influenza Vaccine: A Randomized, Observer-Blind, Controlled Study
por: Roy-Ghanta, Sumita, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_04567b6f8vd4eqfl772an7gftg